A Modified Physiological BCS for Prediction of Intestinal Absorption in Drug Discovery-Reference-Cited by-同舟云学术

A Modified Physiological BCS for Prediction of Intestinal Absorption in Drug Discovery

Published:2010-09-01 Issue:5 Volume:7 Page:1478-1487
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Zaki Noha M.¹,Artursson Per¹,Bergström Christel A. S.¹

Affiliation:

1. The Uppsala University Drug Optimization and Pharmaceutical Profiling Platform, Department of Pharmacy, Uppsala University, Biomedical Center P.O. Box 580, SE-751 23 Uppsala, Sweden

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/mp100124f

Reference44 articles.

1. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

2. The Influence of Target Family and Functional Activity on the Physicochemical Properties of Pre-Clinical Compounds

3. High throughput solubility measurement in drug discovery and development

4. Poorly Soluble Marketed Drugs Display Solvation Limited Solubility

5. Powder Dissolution Method for Estimating Rotating Disk Intrinsic Dissolution Rates of Low Solubility Drugs

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of Printability of PVA-Based Tablets from Powder and Assessment of Critical Rheological Parameters;Pharmaceutics;2024-04-19

2. Therapeutic drug monitoring of osimertinib in non‐small cell lung cancer and short bowel syndrome: A case report;British Journal of Clinical Pharmacology;2023-10-26

3. Structural Investigation on How Guest Loading of Poly(2-oxazoline)-Based Micelles Affects the Interaction with Simulated Intestinal Fluids;ACS Biomaterials Science & Engineering;2023-07-13

4. Fed intestinal solubility limits and distributions applied to the Developability classification system;European Journal of Pharmaceutics and Biopharmaceutics;2023-05

5. Concentration and composition dependent aggregation of Pluronic- and Poly-(2-oxazolin)-Efavirenz formulations in biorelevant media;Journal of Colloid and Interface Science;2022-01